Table 1 Basic characteristics of the study population (N=59,503)
Characteristic | N (%) |
|---|---|
Age group (yrs) | |
 Median (min - max) | 44.2 (36.1 – 53.2) |
 15 – <25 | 3,862 (6.5) |
 25 – <35 | 9,710 (16.3) |
 35 – <45 | 16,734 (28.1) |
 45 – <55 | 16,516 (27.8) |
 55+ | 12,681 (21.3) |
Sex | |
 Female | 41,304 (69.4) |
 Male | 18,199 (30.6) |
District | |
 Handeni | 6,603 (11.1) |
 Kilindi | 2,282 (3.8) |
 Korogwe | 9,776 (16.4) |
 Lushoto | 6,035 (10.1) |
 Mkinga | 2,723 (4.6) |
 Muheza | 11,444 (19.3) |
 Pangani | 3,319 (5.6) |
 Tanga | 17,321 (29.1) |
Facility Level | |
 Hospital | 8,659 (18.2) |
 Health Center | 28,293 (59.4) |
 Dispensary | 10,687 (22.4) |
BMI, kg/m2 | |
 <18.5 | 2,686 (4.5) |
 18.5 – <25 | 45,307 (76) |
 25–<30 | 7,076 (12) |
 30+ | 4,434 (7.5) |
WHO stage | |
 I | 12,120 (24) |
 II | 7,730 (15.2) |
 III | 25,217 (49.5) |
 IV | 5,889 (11.6) |
CD4 count, cells/mm3 | |
 <350 | 8,082 (28) |
 350 – 500 | 6,143 (22) |
 500+ | 14,102 (50) |
Marital status | |
 Cohabiting | 924 (1.7) |
 Divorced | 9,564 (17.4) |
 Married | 28,602 (52) |
 Single | 15,972 (29) |
ART duration (yrs) | |
 <=1 | 2,375 (4.0) |
 >1 | 57,128 (96.0) |
Adherence | |
 Good | 57,480 (96.6) |
 Poor | 2,023 (3.4) |
Regimen | |
 First line | 58,176 (98.0) |
 Second line | 1,256 (2.0) |
DTG/TLD based drug | |
 Yes | 54,564 (91.7) |
 No | 4,939 (8.3) |
VLR suppression failure | |
 No | 57,213 (96.0) |
 Yes | 2,290 (4.0) |